Cargando…

Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer

OBJECTIVES: The aim of this study was to investigate 3 Tesla multiparametric magnetic resonance imaging (mpMRI)-based predictors for the pretherapeutic T staging of prostate cancer and their accuracy. METHODS: Consecutive patients with 3 Tesla mpMRI, positive systematic and MR-targeted biopsy, and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Valentin, B., Schimmöller, L., Ullrich, T., Klingebiel, M., Demetrescu, D., Sawicki, L. M., Lakes, J., Mally, D., Quentin, M., Esposito, I., Albers, P., Antoch, G., Arsov, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205913/
https://www.ncbi.nlm.nih.gov/pubmed/33452898
http://dx.doi.org/10.1007/s00261-020-02913-9
_version_ 1783708559067840512
author Valentin, B.
Schimmöller, L.
Ullrich, T.
Klingebiel, M.
Demetrescu, D.
Sawicki, L. M.
Lakes, J.
Mally, D.
Quentin, M.
Esposito, I.
Albers, P.
Antoch, G.
Arsov, C.
author_facet Valentin, B.
Schimmöller, L.
Ullrich, T.
Klingebiel, M.
Demetrescu, D.
Sawicki, L. M.
Lakes, J.
Mally, D.
Quentin, M.
Esposito, I.
Albers, P.
Antoch, G.
Arsov, C.
author_sort Valentin, B.
collection PubMed
description OBJECTIVES: The aim of this study was to investigate 3 Tesla multiparametric magnetic resonance imaging (mpMRI)-based predictors for the pretherapeutic T staging of prostate cancer and their accuracy. METHODS: Consecutive patients with 3 Tesla mpMRI, positive systematic and MR-targeted biopsy, and subsequent radical prostatectomy (RPE) between 01/2016 and 12/2017 were included. MRI parameters such as measurable extraprostatic extension (EPE) (≥ 3 mm), length of (pseudo)capsular contact (LCC), invasion of neurovascular bundle (NVBI), and/or seminal vesicles lesion contact (SVC) or infiltration (SVI) were assessed and correlated to clinical and histopathological results. RESULTS: 136 men were included. In 76 cases, a pT2 stage was determined, in 29 cases a pT3a, and in 31 a pT3b stage. The positive and negative predictive values (PPV, NPV) for the detection of T3 by measurable EPE on MRI was 98% (CI 0.88–1) and 81% (CI 0.72–0.87). No visible NVBI was found in pT2 patients (NPV 100%; CI 0.95–1). ROC analysis for T3a prediction with LCC (AUC 0.81) showed a sensitivity of 87% and a specificity of 62% at a threshold of 12.5 mm (J = 0.485) and 93% and 58% at 11 mm (J(max) = 0.512). All patients with pT3a had a LCC > 5 mm. In case of pT3b, 29/31 patients showed a SVC (PPV 76%, CI 0.61–0.87; NPV 98%, CI 0.93–0.99), and 23/31 patients showed a SVI (PPV 100%, CI 0.86–1; NPV 93%, CI 0.87–0.96). EPE (p < 0.01), LCC (p = 0.05), and SVC (p = 0.01) were independent predictors of pT3. CONCLUSIONS: MRI-measurable EPE, LCC, and SVC were reliable, independent, preoperative predictors for a histopathological T3 stage. A LCC ≥ 11 mm indicated a pT3a stage, whereas a LCC < 5 mm excluded it. On MRI, visible SVI or even SVC of the PCa lesion was reliable preoperative predictors for a pT3b stage. SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00261-020-02913-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-8205913
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-82059132021-07-01 Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer Valentin, B. Schimmöller, L. Ullrich, T. Klingebiel, M. Demetrescu, D. Sawicki, L. M. Lakes, J. Mally, D. Quentin, M. Esposito, I. Albers, P. Antoch, G. Arsov, C. Abdom Radiol (NY) Pelvis OBJECTIVES: The aim of this study was to investigate 3 Tesla multiparametric magnetic resonance imaging (mpMRI)-based predictors for the pretherapeutic T staging of prostate cancer and their accuracy. METHODS: Consecutive patients with 3 Tesla mpMRI, positive systematic and MR-targeted biopsy, and subsequent radical prostatectomy (RPE) between 01/2016 and 12/2017 were included. MRI parameters such as measurable extraprostatic extension (EPE) (≥ 3 mm), length of (pseudo)capsular contact (LCC), invasion of neurovascular bundle (NVBI), and/or seminal vesicles lesion contact (SVC) or infiltration (SVI) were assessed and correlated to clinical and histopathological results. RESULTS: 136 men were included. In 76 cases, a pT2 stage was determined, in 29 cases a pT3a, and in 31 a pT3b stage. The positive and negative predictive values (PPV, NPV) for the detection of T3 by measurable EPE on MRI was 98% (CI 0.88–1) and 81% (CI 0.72–0.87). No visible NVBI was found in pT2 patients (NPV 100%; CI 0.95–1). ROC analysis for T3a prediction with LCC (AUC 0.81) showed a sensitivity of 87% and a specificity of 62% at a threshold of 12.5 mm (J = 0.485) and 93% and 58% at 11 mm (J(max) = 0.512). All patients with pT3a had a LCC > 5 mm. In case of pT3b, 29/31 patients showed a SVC (PPV 76%, CI 0.61–0.87; NPV 98%, CI 0.93–0.99), and 23/31 patients showed a SVI (PPV 100%, CI 0.86–1; NPV 93%, CI 0.87–0.96). EPE (p < 0.01), LCC (p = 0.05), and SVC (p = 0.01) were independent predictors of pT3. CONCLUSIONS: MRI-measurable EPE, LCC, and SVC were reliable, independent, preoperative predictors for a histopathological T3 stage. A LCC ≥ 11 mm indicated a pT3a stage, whereas a LCC < 5 mm excluded it. On MRI, visible SVI or even SVC of the PCa lesion was reliable preoperative predictors for a pT3b stage. SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00261-020-02913-9) contains supplementary material, which is available to authorized users. Springer US 2021-01-16 2021 /pmc/articles/PMC8205913/ /pubmed/33452898 http://dx.doi.org/10.1007/s00261-020-02913-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Pelvis
Valentin, B.
Schimmöller, L.
Ullrich, T.
Klingebiel, M.
Demetrescu, D.
Sawicki, L. M.
Lakes, J.
Mally, D.
Quentin, M.
Esposito, I.
Albers, P.
Antoch, G.
Arsov, C.
Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer
title Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer
title_full Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer
title_fullStr Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer
title_full_unstemmed Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer
title_short Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer
title_sort magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer
topic Pelvis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205913/
https://www.ncbi.nlm.nih.gov/pubmed/33452898
http://dx.doi.org/10.1007/s00261-020-02913-9
work_keys_str_mv AT valentinb magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer
AT schimmollerl magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer
AT ullricht magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer
AT klingebielm magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer
AT demetrescud magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer
AT sawickilm magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer
AT lakesj magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer
AT mallyd magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer
AT quentinm magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer
AT espositoi magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer
AT albersp magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer
AT antochg magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer
AT arsovc magneticresonanceimagingimprovesthepredictionoftumorstaginginlocalizedprostatecancer